Baird Financial Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,000
Closed -$46.4K 1790
2024
Q3
$46.4K Sell
4,000
-13,677
-77% -$129K ﹤0.01% 1728
2024
Q2
$133K Buy
17,677
+2,121
+14% +$17.5K ﹤0.01% 1706
2024
Q1
$156K Buy
15,556
+218
+1% +$2.03K ﹤0.01% 1698
2023
Q4
$143K Sell
15,338
-2,295
-13% -$23.7K ﹤0.01% 1662
2023
Q3
$224K Buy
17,633
+376
+2% +$5.16K ﹤0.01% 1591
2023
Q2
$245K Buy
17,257
+5,446
+46% +$76.5K ﹤0.01% 1566
2023
Q1
$176K Sell
11,811
-1,212
-9% -$18.4K ﹤0.01% 1629
2022
Q4
$193K Buy
13,023
+380
+3% +$6.2K ﹤0.01% 1611
2022
Q3
$209K Sell
12,643
-26,224
-67% -$528K ﹤0.01% 1595
2022
Q2
$817K Buy
38,867
+3,795
+11% +$77.4K ﹤0.01% 1162
2022
Q1
$824K Sell
35,072
-452
-1% -$11.1K ﹤0.01% 1232
2021
Q4
$967K Sell
35,524
-66
-0.2% -$1.77K ﹤0.01% 1210
2021
Q3
$1.01M Buy
35,590
+23,899
+204% +$728K ﹤0.01% 1197
2021
Q2
$352K Hold
11,691
﹤0.01% 1529
2021
Q1
$298K Buy
+11,691
New +$299K ﹤0.01% 1523
2017
Q2
Sell
-41,011
Closed -$2.85M 1237
2017
Q1
$2.85M Buy
41,011
+453
+1% +$31.5K 0.02% 513
2016
Q4
$2.7M Sell
40,558
-4,238
-9% -$276K 0.02% 502
2016
Q3
$2.97M Sell
44,796
-154
-0.3% -$10.5K 0.03% 477
2016
Q2
$3.26M Buy
44,950
+1,599
+4% +$110K 0.03% 439
2016
Q1
$2.8M Buy
43,351
+40
+0.1% +$2.65K 0.03% 466
2015
Q4
$3.1M Buy
43,311
+9,762
+29% +$722K 0.03% 439
2015
Q3
$2.58M Sell
33,549
-741
-2% -$59.8K 0.03% 463
2015
Q2
$2.54M Buy
+34,290
New +$2.47M 0.03% 495

Other funds holding MD

Baird Financial Group's MD Position: Q4 2024 in Review

Baird Financial Group sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 4,000 shares — an estimated $46.4K sold.

Baird Financial Group first reported a position in MD in Q2 2015 and held it in 23 quarters. The position peaked at $3.26M in Q2 2016. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.

  • Baird Financial Group reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 4,000 Pediatrix Medical shares in Q4 2024, an estimated $46.4K.
  • Baird Financial Group first reported a position in Pediatrix Medical in Q2 2015 and held it in 23 quarters.
  • Baird Financial Group's Pediatrix Medical position peaked at $3.26M in Q2 2016.
  • 229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.